Sara Errani's doping suspension has been extended and she's not happy about it.
The Court of Arbitration for Sport announced Errani's initial two-month suspension has been increased to a 10-month suspension, effective immediately.
Watch: Federer Settles GOAT Debate
The two month suspension Errani already served from August 3rd, 2017 through October 2nd, 2017 will be credited against the total 10-month suspension, sidelining the former doubles world No. 1 for the next eight months.
The appeal filed by Errani was dismissed by the CAS.
"I am really disgusted by this matter," Errani said in a statement she posted on Twitter. "I don't think anything similar has ever happened or managed - in my humble opinion - in such a shameful manner."
Trace amounts of Letrozole, classified as a hormone and metabolic modulator, were found in Errani’s urine following a February 16th, 2017 out-of-competition drug test.
The medication, sold under the commercial name Femara, is used in breast-cancer treatment.
Letrozole is also on the World Anti Doping Agency’s list of banned substances because it can be used as a masking agent to cover steroid use.
The former world No. 5 said her mother has been using Femara daily since 2012 “and therefore (it) is present in the house where I am currently living.”
The Italian claims home cooking caused her positive test for Letrozole using the pasta defense in asserting contaminated food was the cause.
Errani said her mother kept the medication on the kitchen counter as a reminder to take it daily and speculates Femara fell into the food during cooking and entered her system during a meal.
“I have explained in details all circumstances to the Independent Tribunal, who agreed that the food contamination was the cause of my positive test,” Errani said. “There is no evidence I have intentionally violated the anti-doping rules; there is no evidence that Letrozole would enhance the performance of a female tennis player.”
Errani defeated four Grand Slam champions—Ana Ivanovic, Svetlana Kuznetsova, Angelique Kerber and Samantha Stosur—en route to the 2012 Roland Garros final where she lost to Maria Sharapova.
Two-time French Open champion Sharapova served a 15-month ban after testing positive for the banned substance meldonium at the 2016 Australian Open.